SubodhJ.SaggiMD

Nephrology • Brooklyn, NY

Professor of Medicine, SUNY-Downstate College of Medicine

Join to view full profile

Dr. Saggi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Saggi's full profile

Already have an account?

Office
470 Clarkson Ave
Ste A
Brooklyn, NY 11203
Phone+1 718-270-3174

Fax+1 718-270-3327

Education & Training

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Nephrology, 1987 - 1992
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1984 - 1987
Topiwala National Medical CollegeClass of 1983

Certifications & Licensure

FL State Medical License 1999 - 2026
NY State Medical License 1987 - 2025
TX State Medical License 1993 - 2016
NJ State Medical License 1998 - 2011
ND State Medical License 1998 - 2003
CT State Medical License 1986 - 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Fellow (ASNF) American Society of Nephrology

Clinical Trials

Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis Start of enrollment: 2011 Apr 01
Completed
Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis Start of enrollment: 2020 Jun 08
Completed
Phase 2
A Study of Felzartamab in Participants With Lupus Nephritis Start of enrollment: 2023 Nov 01
Recruiting
Phase 1
A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD) Start of enrollment: 2013 Oct 31
Completed
Phase 2
Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia Start of enrollment: 2013 Nov 01
Completed
Phase 2
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia Start of enrollment: 2014 Jun 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

69 citations
Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients.
Ranganathan Natarajan, Bohdan Pechenyak, Usha Vyas, Pari Ranganathan, Alan D. Weinberg
Biomed Research International. 2014-07-24
21 citations
Personalized Intervention in Monogenic Stone Formers
Lucas Policastro, Subodh J. Saggi, David S. Goldfarb, Jeffrey P. Weiss
The Journal of Urology. 2018-03-01
258 citations
Diagnostic and Prognostic Stratification in the Emergency Department Using Urinary Biomarkers of Nephron Damage: A Multicenter Prospective Cohort Study
Thomas L. Nickolas, Kai M. Schmidt-Ott, Pietro A. Canetta, Catherine S. Forster, Eugenia Singer
Journal of the American College of Cardiology. 2012-01-17

Professional Memberships

American Society of Nephrology - ASN
Fellow